The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of 18.1% interest in RMS

30 Jun 2020 15:00

RNS Number : 5776R
Braveheart Investment Group plc
30 June 2020
 

30 June 2020

Braveheart Investment Group plc

("Braveheart" or "the Group")

 

Acquisition of 18.1 per cent. interest in Remote Monitoring Systems plc,

Issue of Consideration Shares and Total Voting Rights

 

Braveheart Investment Group (AIM: BRH), is pleased to announce that it has purchased a total of 119,637,590 ordinary shares of 0.2 pence each in Remote Monitoring Systems plc ("RMS" the "Existing RMS Shares") from Trevor Brown at a price of 0.275 pence per share, being the closing mid-market price on 29 June 2020, for a total consideration of £329,003. The consideration will be satisfied by the issue of a total of 2,632,026 new ordinary shares of 2 pence each in Braveheart (the "Consideration Shares"), with the issue price of the Consideration Shares being 12.5 pence each, the closing mid-market price of a Consideration Share on 29 June 2020. Attached to certain of the shares being acquired are warrants over new ordinary shares in RMS which are exercisable at a price of 0.5 pence per share and total 10,000,000 warrants. These warrants are to be assigned to Braveheart for no additional consideration. Upon completion of the transaction, Braveheart will own 18.1 per cent. of the issued share capital of RMS and Trevor Brown will no longer have a holding of ordinary shares in RMS.

 

RMS is an operating company whose ordinary shares are admitted to trading on AIM. In the year ended 31 December 2019, RMS incurred a loss before taxation of £711,942 and as at that date had net liabilities of £19,250. On 9 April 2020, RMS issued 140,000,000 new ordinary shares of 0.2p each at a price of 0.25p per share raising £350,000. As at 29 June 2020, the directors of RMS estimated that RMS had net cash of approximately £266,000.

 

RMS has two trading subsidiaries, GyroMetric Systems Limited ("GyroMetric"), in which it owns a 58 per cent. interest, which develops and manufactures digital monitoring and safeguarding systems for rotating shafts and Cloudveil Limited ("Cloudveil"), an intelligence services and security risk management business, which was acquired in September 2019.

 

Braveheart has a 19.5 per cent. interest in Gyrometric. It is intended that Trevor Brown will remain on the RMS Board to represent Braveheart's interests.

 

Application will be made to the London Stock Exchange for the Consideration Shares to be admitted to trading on AIM ("Admission"). It is anticipated that Admission will occur, and dealings will commence in the Consideration Shares at 8.00 a.m. on, or around, 6 July 2020.

 

Director's holding

 

Upon Admission, Trevor Brown will hold a total beneficial interest in 8,588,288 ordinary shares of 2 pence each in Braveheart, equivalent to approximately 24.75 per cent. of Braveheart's issued share capital.

 

Related Party Transaction

 

The seller of the Existing RMS Shares is Trevor Brown, who is the CEO and a Director of Braveheart and, therefore, the transaction is treated as a related party transaction under the AIM rules. The independent directors, being Jonathan Freeman and Vivian Hallam, consider, having consulted with Allenby Capital Limited, the Company's Nominated Adviser, that the terms of the purchase of the Existing RMS Shares and the issue of the Consideration Shares are fair and reasonable insofar as the shareholders of Braveheart are concerned.

 

Total voting rights

 

Following Admission, the Company will have 34,698,547 ordinary shares of 2 pence each in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of ordinary shares and voting rights will be 34,698,547. This figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information: 

Braveheart Investment Group plc

Tel: 01738 587555

Viv Hallam, Executive Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / Nicholas Chambers

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Brown

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Purchase of ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

12.5p

 

 

Volume(s)

 

2,632,026

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

N/A

 

e)

 

Dates of the transaction

 

30 June 2020

f)

Place of transaction

Off-market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQBXGDLBUXDGGG
Date   Source Headline
2nd Sep 202211:20 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSAcquisition of further interest in Aukett Swanke
31st Aug 20225:00 pmRNSTotal Voting Rights
4th Aug 20223:27 pmRNSHolding(s) in Company
3rd Aug 20225:05 pmRNSAcq of interest in Aukett Swanke plc - Replacement
3rd Aug 20224:10 pmRNSAcquisition of interest in Aukett Swanke Group plc
21st Jul 20227:03 amRNSOperational update on Paraytec
13th Jul 202211:41 amRNSResult of AGM
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
27th Jun 20228:40 amRNSDirector/PDMR Shareholding
16th Jun 20227:00 amRNSFinal Results
9th May 20223:57 pmRNSReplacement - Cancellation and grant of options
9th May 20221:08 pmRNSCancellation and grant of options
29th Apr 20225:00 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSPlacing to raise £215,113
31st Mar 202212:17 pmRNSResult of General Meeting
28th Mar 20229:42 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSNotice of GM and authority to issue shares
14th Mar 202211:23 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSBlock admission six monthly return
8th Mar 20229:41 amRNSDirector/PDMR Shareholding
25th Feb 202211:06 amRNSSecond Price Monitoring Extn
25th Feb 202211:00 amRNSPrice Monitoring Extension
25th Feb 20227:00 amRNSOperational update
31st Jan 20227:00 amRNSHolding(s) in Company
28th Jan 20221:55 pmRNSHolding(s) in Company
21st Jan 20222:46 pmRNSOperational update on Paraytec
17th Jan 20223:23 pmRNSFurther re. Director/PDMR holding
17th Jan 20229:24 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSNon Regulatory - PhaseFocus Update
8th Dec 20214:08 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSOperational update on Paraytec
26th Nov 20219:49 amRNSVideo from The University of Sheffield re Paraytec
15th Nov 20217:00 amRNSHalf-year Report
14th Oct 20211:46 pmRNSDirector/PDMR Shareholding
11th Oct 202111:02 amRNSHolding(s) in Company
11th Oct 20217:30 amRNSInvestment in Autins Group plc
30th Sep 20215:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSOperational update on various investments
28th Sep 202112:14 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSBlock admission six monthly return
31st Aug 20215:00 pmRNSTotal Voting Rights
13th Aug 202111:05 amRNSSecond Price Monitoring Extn
13th Aug 202111:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSPlacing to raise £2.5 million
6th Aug 202111:05 amRNSSecond Price Monitoring Extn
6th Aug 202111:00 amRNSPrice Monitoring Extension
4th Aug 20212:40 pmRNSFurther update re Paraytec AD Scanner project
26th Jul 20215:49 pmRNSDirector/PDMR Shareholding
14th Jul 20212:37 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.